These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16010215)

  • 1. Guidance for first-line treatment of anogenital gonorrhoea infection.
    Tyson M
    Br J Nurs; 2005 Jun 23-Jul 13; 14(12):646-8, 650-2. PubMed ID: 16010215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007-2011.
    Ison CA; Town K; Obi C; Chisholm S; Hughes G; Livermore DM; Lowndes CM;
    Lancet Infect Dis; 2013 Sep; 13(9):762-8. PubMed ID: 23764300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which cephalosporin for gonorrhoea?
    Ison CA; Mouton JW; Jones K; Fenton KA; Livermore DM;
    Sex Transm Infect; 2004 Oct; 80(5):386-8. PubMed ID: 15459407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National surveillance of antimicrobial susceptibility in Neisseria gonorrhoeae in 2005-2006 and recommendations of first-line antimicrobial drugs for gonorrhoea treatment in Russia.
    Kubanova A; Frigo N; Kubanov A; Sidorenko S; Priputnevich T; Vachnina T; Al-Khafaji N; Polevshikova S; Solomka V; Domeika M; Unemo M
    Sex Transm Infect; 2008 Aug; 84(4):285-9. PubMed ID: 18256105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of a Neisseria gonorrhoeae clone showing decreased susceptibility to cefixime in England and Wales.
    Chisholm SA; Alexander S; Desouza-Thomas L; Maclure-Webster E; Anderson J; Nichols T; Lowndes CM; Ison CA;
    J Antimicrob Chemother; 2011 Nov; 66(11):2509-12. PubMed ID: 21846672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended surveillance of gonorrhoea in Scotland 2003.
    Young H; McElhinney J; Palmer HM;
    Int J STD AIDS; 2006 Oct; 17(10):687-92. PubMed ID: 17059639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonorrhoea in 21st century--international and Polish situation.
    Serwin AB; Koper M; Unemo M
    Przegl Epidemiol; 2014; 68(1):39-44, 127-31. PubMed ID: 25004630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stemming the tide of drug-resistant Neisseria gonorrhoeae: the need for an individualized approach to treatment.
    Buono SA; Watson TD; Borenstein LA; Klausner JD; Pandori MW; Godwin HA
    J Antimicrob Chemother; 2015 Feb; 70(2):374-81. PubMed ID: 25331059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010.
    Ison CA; Hussey J; Sankar KN; Evans J; Alexander S
    Euro Surveill; 2011 Apr; 16(14):. PubMed ID: 21492528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Will targeting oropharyngeal gonorrhoea delay the further emergence of drug-resistant Neisseria gonorrhoeae strains?
    Lewis DA
    Sex Transm Infect; 2015 Jun; 91(4):234-7. PubMed ID: 25911525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci.
    Tapsall JW
    Sex Transm Infect; 2009 Aug; 85(4):256-8. PubMed ID: 19261600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial resistance in Neisseria gonorrhoeae in the UK: surveillance and management.
    Ison CA; Alexander S
    Expert Rev Anti Infect Ther; 2011 Oct; 9(10):867-76. PubMed ID: 21973299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cephalosporin and azithromycin susceptibility in Neisseria gonorrhoeae isolates by site of infection, British Columbia, 2006 to 2011.
    Hottes TS; Lester RT; Hoang LM; McKay R; Imperial M; Gilbert M; Patrick D; Wong T; Martin I; Ogilvie G
    Sex Transm Dis; 2013 Jan; 40(1):46-51. PubMed ID: 23250301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial resistance monitoring in Neisseria gonorrhoeae and strategic use of funds from the Global Fund to set up a systematic Moroccan gonococcal antimicrobial surveillance programme.
    Hançali A; Ndowa F; Bellaji B; Bennani A; Kettani A; Charof R; El Aouad R
    Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv24-7. PubMed ID: 24037141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global resistance of Neisseria gonorrhoeae: when theory becomes reality.
    Lewis DA
    Curr Opin Infect Dis; 2014 Feb; 27(1):62-7. PubMed ID: 24275696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cephalosporin susceptibility among Neisseria gonorrhoeae isolates--United States, 2000-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(26):873-7. PubMed ID: 21734634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An audit of pharyngeal gonorrhoea treatment in a public sexual health clinic in Adelaide, South Australia.
    Hustig A; Bell C; Waddell R
    Int J STD AIDS; 2013 May; 24(5):399-400. PubMed ID: 23970709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neisseria gonorrhoeae: antimicrobial resistance and study of population dynamics. Situation in Barcelona in 2011].
    Serra-Pladevall J; Barberá-Gracia MJ; Roig-Carbajosa G; Juvé-Saumell R; Gonzalez-Lopez JJ; Bartolomé-Comas R; Andreu-Domingo A
    Enferm Infecc Microbiol Clin; 2013 Nov; 31(9):579-83. PubMed ID: 23623686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the '2012 IUSTI ECCG report on the diagnosis and management of Neisseria gonorrhoeae infections in Europe' depict the situation in Europe?
    Unemo M; Brooks B; Cole M; Ross JD; White JA; Patel R;
    Int J STD AIDS; 2013 Jun; 24(6):423-6. PubMed ID: 23970742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Aug; 61(31):590-4. PubMed ID: 22874837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.